
Reset all filters
01 2Gowling WLG (Canada) LLP
Reset all filters
01 12891476
02 12924360
Reset all filters
01 2LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
Reset all filters
01 2SOLUTION
Reset all filters
01 12033-11-14
02 12034-10-17
Patent Expiration Date : 2034-10-17
Date Granted : 2022-04-26
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
Brand Name : PLUVICTO
Patent Number : 2924360
Filing Date : 2014-10-17
Strength per Unit : 1 000 MBq / mL at calibration
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2034-10-17
Date Granted : 2022-04-26
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2033-11-14
Date Granted : 2022-07-05
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN
Brand Name : PLUVICTO
Patent Number : 2891476
Filing Date : 2013-11-14
Strength per Unit : 1 000 MBq / mL at calibration
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2033-11-14
Date Granted : 2022-07-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF